K
Katherine Shear
Researcher at Columbia University
Publications - 45
Citations - 5493
Katherine Shear is an academic researcher from Columbia University. The author has contributed to research in topics: Complicated grief & Grief. The author has an hindex of 24, co-authored 45 publications receiving 4960 citations. Previous affiliations of Katherine Shear include University of California, San Diego & Cornell University.
Papers
More filters
Journal ArticleDOI
Treatment of complicated grief: a randomized controlled trial
TL;DR: Complicated grief treatment is an improved treatment over interpersonal psychotherapy, showing higher response rates and faster time to response.
Journal ArticleDOI
The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.
Ronald C. Kessler,Wai Tat Chiu,Robert Jin,Ayelet Meron Ruscio,Katherine Shear,Ellen E. Walters +5 more
TL;DR: Although the major societal burden of panic is caused by PD and PA-AG, isolated PAs also have high prevalence and meaningful role impairment, and 4 subgroups are significantly comorbid with other lifetime DSM-IV disorders.
Book ChapterDOI
Epidemiology of Anxiety Disorders
TL;DR: The overall prevalence of anxiety disorders is shown to be quite high, but with considerable variation from the most prevalent (specific phobias) to the least prevalent (agoraphobia without a history of panic disorder) disorders.
Journal ArticleDOI
Attachment, loss, and complicated grief
Katherine Shear,Harry N. Shair +1 more
TL;DR: This work proposes a provisional model of bereavement, guided by Myron Hofer's question "What exactly is lost when a loved one dies", and integrates insights about biobehavioral regulation from Hofer’s animal studies of infant separation, research on adult human attachment, and new ideas from bereavement research.
Journal Article
Clomipramine in the treatment of patients with obsessive-compulsive disorder
Joseph DeVeaugh-Geiss,Richard J. Katz,P. Landau,Hagop S. Akiskal,Jambur Ananth,James C. Ballenger,Wilmer C. Betts,Bruce I. Diamond,Alan Feiger,Edna B. Foa,David Fogelson,Wayne K. Goodman,John H. Greist,Jonathan M. Himmelhoch,Rudolf Hoehn-Saric,Michael A. Jenike,Suck Won Kim,Michael R. Liebowitz,Matig Mavissakalian,Philip T. Ninan,Russell Noyes,Steven A. Rasmussen,Alan Ringold,Katherine Shear +23 more
TL;DR: Clomipramine was generally well tolerated and was effective in reducing obsessive and compulsive symptoms and was superior on the basis of the physicians' and patients' evaluations of global therapeutic change.